US2023193375A1PendingUtilityA1
Method for the detection and quantification of genetic alterations
Assignee: LUCENCE LIFE SCIENCES PTE LTDPriority: Jun 25, 2018Filed: Oct 31, 2022Published: Jun 22, 2023
Est. expiryJun 25, 2038(~11.9 yrs left)· nominal 20-yr term from priority
C12Q 2600/156C12Q 1/6876C12Q 1/6869C12Q 1/6853C12Q 1/6827
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method of simultaneously capturing and identifying distinct targets within a DNA sample, wherein the distinct targets comprise a defined target region and an undefined target region, wherein the undefined target region comprises a structural variation or rearrangement or fusion. Also disclosed is a kit comprising the reagents for use in the methods as described herein.
Claims
exact text as granted — not AI-modified1 - 30 . (canceled)
31 . A kit comprising:
a plurality of primer A, primer A comprising a barcode sequence and a target-specific sequence A, wherein the target-specific sequence A is an oligonucleotide complementary to a sequence at or close to a 3′ end of a single strand of a double stranded DNA fragment A; a plurality of primer B, primer B comprising a separation molecule, a barcode sequence, and a target-specific sequence B, wherein the target-specific sequence B is an oligonucleotide complementary to a sequence within a single strand of a double stranded DNA fragment B; a plurality of primer C, primer C comprising a target-specific sequence C that is an oligonucleotide complementary to a sequence at or close to a 3′ end of the primer A, wherein the primer A is elongated and complementary to the single strand of the double stranded DNA fragment A; a bead that binds the separation molecule, and a double stranded oligonucleotide comprising a nucleotide overhang that is complementary to a 3′ end of the primer B, wherein the primer B is elongated and complementary to the single strand of the double stranded DNA fragment B, and wherein the elongated primer B and the single strand of the double stranded DNA fragment B form a double stranded product B.
32 . The kit according to claim 31 , wherein the kit further comprises a DNA polymerase, a Taq polymerase, a ligase, and a plurality of deoxyribonucleotide triphosphate (dNTPs).
33 . The kit according to claim 31 , wherein the 3′ end of the elongated primer B of the double stranded product B further comprises an additional single nucleotide.Join the waitlist — get patent alerts
Track US2023193375A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.